CHA News Article

Curlin IV Sets Recalled

Moog Medical Devices Group has voluntarily issued a recall of Curlin Intravenous (IV) Administration Sets with lot numbers sold and distributed between December 2011 and May 2012. The Food Drug Administration (FDA) advises immediate discontinuation of the Curlin IV Sets,which have the potential to cause serious injury or death due to blood loss, under-delivery of prescribed medication/fluid or potential delay in therapy. To date, customer complaints have identified three out of 522,900 suspect sets manufactured for the U.S.; however, there have been no reports of injury or death as a result of the sets. The California Department of Public Health issued the attached All Facility Letter with packaging codes and lot numbers. Health care professionals and patients are encouraged to report any adverse events or side effects related to the use of these products to the FDA’s MedWatch Adverse Event Reporting Program at www.fda.gov/Safety/MedWatch.

Commands